CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Germany

Invite Credit Card Holder to pay

Requester Details

Credit Card Holder Details

Company Details

Message to be included

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Germany”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Germany. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Germany. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

In 2016, Germany population was approximately at 82.2 million. The German pharmaceutical market is the largest in Europe and the third largest in the world after the US and Japan. The market value increased from €37.8 billion ($48.6 billion) in 2009 to €52.9 billion ($67.9 billion) in 2016, at a Compound Annual Growth Rate (CAGR) of 4.9%. The market value comprises revenues from drug stores and discount stores, including taxes. The value of the market is expected to reach €67.2 billion ($86.3 billion) in 2021. The medical device market was valued at $21.1 billion in 2009 and increased to $27.5 billion in 2016. It is expected to grow at a CAGR of 4.5% from $28.8 billion in 2017 to $34.4 billion in 2021. These positive trends can primarily be attributed to:

  • An increasing elderly population in Germany, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices
  • Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Germany, and includes:

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Sanofi, Bayer, Roche and Pfizer) and profiles and SWOT analyses of the major players in the medical device market (Johnson & Johnson, Medtronic, Baxter International and B.Braun)
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the German healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

  • Develop business strategies by understanding the trends shaping and driving German healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in German healthcare market

Table of Contents

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Executive Summary

3 Introduction

3.1 GlobalData ...

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Executive Summary

3 Introduction

3.1 GlobalData Report Guidance

4 Overview of the Pharmaceutical and Medical Device Markets

4.1 Pharmaceutical Market

4.1.1 Market Overview

4.1.2 Pharmaceutical Imports and Exports

4.1.3 Supply Channels

4.1.4 Market Segments

4.1.5 Overview of Top Five Disease Areas

4.1.6 Major Players

4.2 Medical Device Market

4.2.1 Market Overview

4.2.2 Overview of Top Five Segments

4.2.3 Major Players

4.3 Market Drivers and Barriers

4.3.1 Drivers

4.3.2 Barriers

5 Market Access

5.1 Reimbursement and Payer Landscape

5.1.1 Overview of Healthcare System

5.1.2 Reimbursement Process

5.1.3 Overview of Insurance Providers

5.1.4 Patient Share in Healthcare Spending

5.1.5 Price Trend in Healthcare Services

5.1.6 Pricing Policies

5.2 Regulatory Landscape

5.2.1 Overview of Regulatory Agencies

5.2.2 No table of figures entries found.Market Authorization Procedure for Pharmaceutical Products

5.2.3 Market Authorization Procedure for Medical Devices

5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing

5.2.5 Licensing Process for Pharmaceutical Exports and Imports

5.2.6 Intellectual Property Rights

5.2.7 Clinical Trial Regulations

5.2.8 Pharmaceutical Advertising Regulations

5.2.9 Pharmacy Regulations

5.2.10 Labeling and Packaging Regulations

6 Country Analysis

6.1 Political Environment

6.1.1 Political Structure

6.1.2 Analysis of the Current Political Environment

6.1.3 Healthcare Policy Initiatives

6.2 Economic Landscape

6.3 Economic Indicators

6.3.1 Gross Domestic Product

6.3.2 Gross National Income

6.3.3 Inflation

6.3.4 Currency Exchange Rate

6.3.5 Foreign Direct Investment

6.3.6 Foreign Exchange Reserves

6.3.7 Trade Balance

6.3.8 General Government Structural Balance

6.3.9 General Government Net Debt

6.3.10 Major Industries

6.4 Demographics

6.4.1 Population

6.4.2 Urban–Rural Share

6.4.3 Distribution by Age Group

6.4.4 Birth Rate

6.4.5 Mortality

6.4.6 Causes of Mortality

6.4.7 Health Status by Gender and Age

6.4.8 Education and Literacy

6.4.9 Employment

6.4.10 Disease Burden

6.5 Healthcare Infrastructure

6.5.1 Healthcare Facilities

6.5.2 Healthcare Parameters

6.5.3 Environmental Health

6.5.4 Healthcare Personnel

6.6 Healthcare Expenditure

6.6.1 Overview

6.6.2 Public–Private Sector Share

6.6.3 Major Components of Healthcare Spending

6.6.4 Spending in Science and Technology Research and Development

6.7 Trade Associations

6.7.1 The Association of Research Based Pharmaceutical Companies

6.7.2 The Federation of Pharmaceutical Manufacture

6.7.3 The Federation of Pharmaceutical Industry

6.8 Trade Fairs

7 Opportunities and Challenges

7.1 Opportunities

7.2 Challenges

8 Appendix

8.1 Abbreviations

8.2 Bibliography

8.3 Research Methodology

8.3.1 Coverage

8.3.2 Secondary Research

8.3.3 Forecasts

8.3.4 Expert Panel

8.4 Contact Us

8.5 Disclaimer

List of tables

List of Tables

Table 1: Pharmaceutical Market, Germany, Revenue ($bn), 2009–2016

Table 2: Pharmaceutical Market, Germany, Revenue Forecast ($bn), 2017–2021

Table 3: Pharmaceutical ...

List of Tables

Table 1: Pharmaceutical Market, Germany, Revenue ($bn), 2009–2016

Table 2: Pharmaceutical Market, Germany, Revenue Forecast ($bn), 2017–2021

Table 3: Pharmaceutical Market, Germany, Pharmaceutical Imports and Exports ($bn), 2009–2015

Table 4: Pharmaceutical Market, Germany, Wholesale Mark-up for Proprietary Medicinal Products ($bn), 2017

Table 5: Pharmaceutical Market, Germany, Retail Pharmacy Mark-up for Proprietary Medicinal Products ($bn), 2017

Table 6: Pharmaceutical Market, Germany, Generic Pharmaceutical Market Revenue ($bn), 2009–2016

Table 7: Pharmaceutical Market, Germany, Biological Drugs in Pipeline and Approved, 2009–2015

Table 8: Pharmaceutical Market, Germany, OTC Drug Market Revenue ($bn), 2009–2016

Table 9: Pharmaceutical Market, Germany, Major OTC Drug Classes, Revenue ($m), 2015

Table 10: Pharmaceutical Market, Germany, Major Disease Areas, Total Cost of Illness ($bn), 2008

Table 11: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016

Table 12: Pharmaceutical Market, Novartis, Planned Filings, 2017–2020

Table 13: Sanofi, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016

Table 14: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2017

Table 15: Bayer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016

Table 16: Pharmaceutical Market, Roche, Global, Revenue ($m) and Annual Growth (%) of Major Products, 2016

Table 17: Pharmaceutical Market, Roche, Global, Late-stage Pipeline, 2017

Table 18: Pharmaceutical Market, Pfizer, Global, Revenue ($m) and Annual Growth (%) of Major Products, 2016

Table 19: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2017

Table 20: Medical Device Market, Germany, Revenue ($bn), 2009–2016

Table 21: Medical Device Market, Germany, Revenue Forecast ($bn), 2017–2021

Table 22: Medical Device Market, Germany, Revenue by Segment ($bn), 2016

Table 23: Ophthalmic Devices Market, Germany, Revenue ($bn), 2009–2016

Table 24: Wound Care Management Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2012

Table 25: Orthopedic Devices Market, Germany, Revenue ($bn), 2009–2016

Table 26: Orthopedic Devices Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2016

Table 27: Ophthalmic Devices Market, Germany, Revenue ($bn), 2009–2016

Table 28: Ophthalmic Devices Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2015

Table 29: Cardiovascular Devices Market, Germany, Revenue of Major Players ($bn), 2009–2016

Table 30: Cardiovascular Devices Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2015

Table 31: IVD Market, Germany, Revenue ($bn), 2009–2016

Table 32: IVD Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2014

Table 33: Medical Device Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2012

Table 34: Medical Device Market, Medtronic, Major Products, 2016

Table 35: Baxter International, Global, Major Products, 2017

Table 36: Market Access, Germany, Number of SHI Providers, 2009-2017

Table 37: Market Access, Germany, Out-of-Pocket Expenditure (%), 2009–2015

Table 38: Market Access, Germany, Healthcare Price Index, Annual Change (%), 2009–2016

Table 39: Market Access, Germany, Early Assessment of Drugs, 2013

Table 40: Market Access, Germany, Patent Application Fees, 2017

Table 41: Market Access, Germany, Trademark Registration Fees, 2017

Table 42: Market Access, Germany, Voluntary Harmonization Procedure, 2017

Table 43: Economic Indicators, Germany, Gross Domestic Product per Capita ($), 2009–2016

Table 44: Economic Indicators, Germany, Gross Domestic Product per Capita Forecast ($), 2017–2021

Table 45: Economic Indicators, Germany, Gross Domestic Product Annual Growth (%), 2009–2016

Table 46: Economic Indicators, Germany, Gross Domestic Product Annual Growth Forecast (%), 2017–2021

Table 47: Economic Indicators, Germany, Gross National Income per Capita ($), 2009–2016

Table 48: Economic Indicators, Germany, Average Consumer Price Index, 2009–2016

Table 49: Economic Indicators, Germany, Average Consumer Price Annual Change (%), 2009–2016

Table 50: Economic Indicators, Germany, Currency Exchange Rate (€ per $), 2009–2016

Table 51: Economic Indicators, Germany, Foreign Direct Investment ($bn), 2009–2015

Table 52: Economic Indicators, Germany, Foreign Exchange Reserves ($bn), 2009–2016

Table 53: Economic Indicators, Germany, Imports of Goods and Services ($bn), 2009–2016

Table 54: Economic Indicators, Germany, Exports of Goods and Services ($bn), 2009–2016

Table 55: Economic Indicators, Germany, Government Structural Balance ($bn), 2009–2016

Table 56: Economic Indicators, Germany, General Government Net Debt ($bn), 2009–2016

Table 57: Economic Indicators, Germany, Major Industries by Revenue ($bn), 2015

Table 58: Demographics, Germany, Population (million), 2009–2016

Table 59: Demographics, Germany, Population (million), 2017–2021

Table 60: Demographics, Germany, Urban–Rural Population Share (%), 2009–2016

Table 61: Demographics, Germany, Population Distribution by Age Group (%), 2009–2016

Table 62: Demographics, Germany, Population Distribution by Age Group Forecast (%), 2017–2021

Table 63: Demographics, Germany, Births (per 1,000 population), 2009–2016

Table 64: Demographics, Germany, Mortality (per 1,000 population), 2009–2016

Table 65: Economic Indicators, Germany, Major Causes of Mortality, 2015

Table 66: Demographics, Germany, Infant Mortality (per 1,000 live births), 2009–2016

Table 67: Demographics, Germany, Immunization Rate (%), 2009–2016

Table 68: Demographics, Germany, Major Causes of Male Mortality, 2015

Table 69: Demographics, Germany, Major Causes of Female Mortality, 2015

Table 70: Demographics, Germany, Gender Ratio (M/F), 2009–2016

Table 71: Demographics, Germany, Life Expectancy at Birth (years), 2009–2016

Table 72: Demographics, Germany, Highest Level of General Education Completed, Share (%), 2015

Table 73: Demographics, Germany, Vocational Qualification, Share (%), 2015

Table 74: Demographics, Germany, Unemployment Rate (%), 2009–2016

Table 75: Demographics, Germany, Most Frequently Diagnosed Diseases (‘000), 2015

Table 76: Demographics, Germany, Disability-Adjusted Life Years by Major Disease (‘000), 2012

Table 77: Healthcare Infrastructure, Germany, Number of Hospitals, 2009–2015

Table 78: Healthcare Infrastructure, Germany, Acute Care Hospitals (per 10,000 population), 2009–2015

Table 79: Healthcare Infrastructure, Germany, Diagnostic Equipment (per million population), 2009–2015

Table 80: Healthcare Infrastructure, Germany, Hospital Beds (per 1,000 population), 2009–2015

Table 81: Healthcare Infrastructure, Germany, Acute Care Hospital Beds (per 1,000 population), 2009–2015

Table 82: Healthcare Infrastructure, Germany, Psychiatric Hospital Beds (per 1,000 population), 2009–2015

Table 83: Healthcare Infrastructure, Germany, PM2.5 (µg per m3), 2009–2015

Table 84: Healthcare Infrastructure, Germany, CO2 Emissions (million metric tons), 2009–2015

Table 85: Healthcare Infrastructure, Germany, Healthcare Personnel (‘000), 2009–2015

Table 86: Healthcare Infrastructure, Germany, Doctors (per 1,000 population), 2009–2015

Table 87: Healthcare Infrastructure, Germany, Dentists (per 1,000 population), 2009–2015

Table 88: Healthcare Infrastructure, Germany, Pharmacists (per 1,000 population), 2009–2015

Table 89: Healthcare Infrastructure, Germany, Nurses (per 1,000 population), 2009–2015

Table 90: Healthcare Expenditure, Germany, Healthcare Expenditure as Percentage of GDP (%), 2009–2015

Table 91: Healthcare Expenditure, Germany, Public–Private Share (%), 2009–2015

Table 92: Healthcare Expenditure, Germany, Public–Private Share (%), 2015

Table 93: Healthcare Expenditure, Germany, R&D Expenditure as Percentage of GDP (%), 2009–2015

Table 94: Healthcare Expenditure, Germany, Major Healthcare Trade Fairs, 2017

List of figures

List of Figures

Figure 1: Pharmaceutical Market, Germany, Revenue ($bn), 2009–2021

Figure 2: Medical Device Market, Germany, Revenue ($bn), 2009–2021

Figure 3: Country ...

List of Figures

Figure 1: Pharmaceutical Market, Germany, Revenue ($bn), 2009–2021

Figure 2: Medical Device Market, Germany, Revenue ($bn), 2009–2021

Figure 3: Country Profile, Germany, 2016

Figure 4: Pharmaceutical Market, Germany, Revenue ($bn), 2009–2016

Figure 5: Pharmaceutical Market, Germany, Revenue Forecast ($bn), 2017–2021

Figure 6: Pharmaceutical Market, Germany, Pharmaceutical Imports and Exports ($bn), 2009–2015

Figure 7: Pharmaceutical Market, Germany, Supply Channel, 2017

Figure 8: Pharmaceutical Market, Germany, Generic Pharmaceutical Market Revenue ($bn), 2008–2016

Figure 9: Pharmaceutical Market, Germany, Biological Drugs in Pipeline and Approved, 2009–2015

Figure 10: Pharmaceutical Market, Germany, OTC Drug Market Revenue ($bn), 2009-2016

Figure 11: Pharmaceutical Market, Germany, Major OTC Drug Classes, Revenue ($m), 2015

Figure 12: Pharmaceutical Market, Germany, Major Disease Areas, Total Cost of Illness ($bn), 2008

Figure 13: Medical Device Market, Germany, Revenue ($bn), 2009–2016

Figure 14: Medical Device Market, Germany, Revenue Forecast ($bn), 2017–2021

Figure 15: Medical Device Market, Germany, Revenue by Segment ($bn), 2016

Figure 16: Wound Care Management Market, Germany, Revenue ($bn), 2009–2016

Figure 17: Wound Care Management Market, Germany, Market Share of Major Players (%), 2012

Figure 18: Orthopedic Devices Market, Germany, Revenue ($bn), 2009–2016

Figure 19: Orthopedic Devices Market, Germany, Market Share of Major Players (%), 2016

Figure 20: Ophthalmic Devices Market, Germany, Revenue ($bn), 2009–2016

Figure 21: Ophthalmic Devices Market, Germany, Market Share of Major Players (%), 2015

Figure 22: Cardiovascular Devices Market, Germany, Revenue ($bn), 2009–2016

Figure 23: Cardiovascular Devices Market, Germany, Market Share of Major Players (%), 2015

Figure 24: IVD Market, Germany, Revenue ($bn), 2009–2016

Figure 25: IVD Market, Germany, Market Share of Major Companies (%), 2014

Figure 26: Medical Device Market, Germany, Revenue of Major Companies ($m), 2012

Figure 27: Healthcare Market, Germany, Drivers and Barriers, 2017

Figure 28: Market Access, Germany, Roles of Regulatory Bodies, 2017

Figure 29: Market Access, Germany, Reimbursement Process, 2017

Figure 30: Market Access, Germany, Number of SHI Providers, 2009-2017

Figure 31: Market Access, Germany, Out-of-Pocket Expenditure (%), 2009–2015

Figure 32: Market Access, Germany, Healthcare Price Index, Annual Change (%), 2009–2016

Figure 33: Market Access, Germany, AMNOG Reimbursement Process for Drugs, 2017

Figure 34: Market Access, Germany, Organizational Structure of BfArM, 2017

Figure 35: Market Access, Germany, Organizational Structure of PEI, 2017

Figure 36: Market Access, EU, Centralized Procedure, Market Authorization, Pre-submission Phase, 2017

Figure 37: Market Access, EU, Centralized Procedure, Market Authorization, Pre-opinion Phase, 2017

Figure 38: Market Access, EU, Centralized Procedure, Market Authorization, Post-opinion Phase, 2017

Figure 39: Market Access, EU, Decentralized Procedure, Market Authorization, 2017

Figure 40: Market Access, EU, Conformity Assessment of Class I Medical Devices, 2017

Figure 41: Market Access, EU, Conformity Assessment of Class IIa Medical Devices, 2017

Figure 42: Market Access, EU, Conformity Assessment of Class IIb Medical Devices, 2017

Figure 43: Market Access, EU, Conformity Assessment of Class III Medical Devices, 2017

Figure 44: Market Access, Germany, Patent Approval Process, 2017

Figure 45: Market Access, Germany, Trademark Approval Process, 2017

Figure 46: Economic Indicators, Germany, Gross Domestic Product per Capita ($), 2009–2016

Figure 47: Economic Indicators, Germany, Gross Domestic Product per Capita Forecast ($), 2017–2021

Figure 48: Economic Indicators, Germany, Gross Domestic Product Annual Growth (%), 2009–2016

Figure 49: Economic Indicators, Germany, Gross Domestic Product Annual Growth Forecast (%), 2017–2021

Figure 50: Economic Indicators, Germany, Gross National Income per Capita ($), 2009–2016

Figure 51: Economic Indicators, Germany, Average Consumer Price Index, 2009–2016

Figure 52: Economic Indicators, Germany, Average Consumer Price Annual Change (%), 2009–2016

Figure 53: Economic Indicators, Germany, Currency Exchange Rate (€ per $), 2009–2016

Figure 54: Economic Indicators, Germany, Foreign Direct Investment ($bn), 2009–2015

Figure 55: Economic Indicators, Germany, Foreign Exchange Reserves ($bn), 2009–2016

Figure 56: Economic Indicators, Germany, Imports of Goods and Services ($bn), 2009–2016

Figure 57: Economic Indicators, Germany, Exports of Goods and Services ($bn), 2009–2016

Figure 58: Economic Indicators, Germany, Government Structural Balance ($bn), 2009–2016

Figure 59: Economic Indicators, Germany, General Government Net Debt ($bn), 2009–2016

Figure 60: Economic Indicators, Germany, Major Industries by Revenue ($bn), 2015

Figure 61: Demographics, Germany, Population (million), 2009–2016

Figure 62: Demographics, Germany, Population (million), 2017–2021

Figure 63: Demographics, Germany, Urban–Rural Population Share (%), 2009–2016

Figure 64: Demographics, Germany, Population Distribution by Age Group (%), 2009–2016

Figure 65: Demographics, Germany, Population Distribution by Age Group Forecast (%), 2017–2021

Figure 66: Demographics, Germany, Births (per 1,000 population), 2009–2016

Figure 67: Demographics, Germany, Mortality (per 1,000 population), 2009–2016

Figure 68: Demographics, Germany, Major Causes of Mortality, 2015

Figure 69: Demographics, Germany, Infant Mortality (per 1,000 live births), 2009–2016

Figure 70: Demographics, Germany, Immunization Rate (%), 2009–2016

Figure 71: Demographics, Germany, Major Causes of Male Mortality, 2015

Figure 72: Demographics, Germany, Major Causes of Female Mortality, 2015

Figure 73: Demographics, Germany, Gender Ratio (M/F), 2009–2016

Figure 74: Demographics, Germany, Life Expectancy at Birth (years), 2009–2016

Figure 75: Demographics, Germany, Highest Level of General Education Completed, Share (%), 2015

Figure 76: Demographics, Germany, Vocational Qualification, Share (%), 2015

Figure 77: Demographics, Germany, Unemployment Rate (%), 2009–2016

Figure 78: Demographics, Germany, Most Frequently Diagnosed Diseases (‘000), 2015

Figure 79: Demographics, Germany, Disability-Adjusted Life Years by Major Disease (‘000), 2012

Figure 80: Healthcare Infrastructure, Germany, Number of Hospitals, 2009–2015

Figure 81: Healthcare Infrastructure, Germany, Acute Care Hospitals (per 10,000 population), 2009–2015

Figure 82: Healthcare Infrastructure, Germany, Diagnostic Equipment (per million population), 2009–2015

Figure 83: Healthcare Infrastructure, Germany, Hospital Beds (per 1,000 population), 2009–2015

Figure 84: Healthcare Infrastructure, Germany, Acute Care Hospital Beds (per 1,000 population), 2009–2015

Figure 85: Healthcare Infrastructure, Germany, Psychiatric Hospital Beds (per 1,000 population), 2009–2015

Figure 86: Healthcare Infrastructure, Germany, PM2.5 (µg per m3), 2009–2015

Figure 87: Healthcare Infrastructure, Germany, CO2 Emissions (million metric tons), 2009–2015

Figure 88: Healthcare Infrastructure, Germany, Healthcare Personnel (‘000), 2009-2015

Figure 89: Healthcare Infrastructure, Germany, Physicians (per 1,000 population), 2009–2015

Figure 90: Healthcare Infrastructure, Germany, Dentists (per 1,000 population), 2009–2015

Figure 91: Healthcare Infrastructure, Germany, Pharmacists (per 1,000 population), 2009–2015

Figure 92: Healthcare Infrastructure, Germany, Nurses (per 1,000 population), 2009–2015

Figure 93: Healthcare Expenditure, Germany, Healthcare Expenditure as Percentage of GDP (%), 2009–2015

Figure 94: Healthcare Expenditure, Germany, Public–Private Share (%), 2009–2015

Figure 95: Healthcare Expenditure, Germany, Public–Private Share (%), 2015

Figure 96: Healthcare Expenditure, Germany, R&D Expenditure as Percentage of GDP (%), 2009–2015

Figure 97: Healthcare Market, Germany, Opportunities and Challenges, 2017

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Saved reports

We find GlobalData’s reports and models very helpful.

  DRI Capital